NASDAQ:SIEN Sientra (SIEN) Stock Price, News & Analysis → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free SIEN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.17▼$0.6852-Week Range N/AVolume3.44 million shsAverage Volume4.15 million shsMarket Capitalization$2.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get Sientra alerts: Email Address Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. About Sientra Stock (NASDAQ:SIEN)Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Read More Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. SIEN Stock News HeadlinesApril 22, 2024 | morningstar.comSientra Inc SIENQApril 18, 2024 | finance.yahoo.comNuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis PortfolioApril 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...April 11, 2024 | markets.businessinsider.comNasdaq (NDAQ) Initiated with a Buy at BarclaysApril 3, 2024 | finanznachrichten.deSientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionApril 3, 2024 | finance.yahoo.comNuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment BrandApril 2, 2024 | globenewswire.comSientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionMarch 15, 2024 | finance.yahoo.comGlobal Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%April 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...March 7, 2024 | wsj.comFirm Retention Summary: SientraFebruary 17, 2024 | finance.yahoo.comSIEN Mar 2024 2.500 callFebruary 15, 2024 | finanznachrichten.deSientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessFebruary 15, 2024 | msn.comPlastic surgery company goes bust, files Chapter 11 bankruptcyFebruary 15, 2024 | msn.comPlastic-surgery company goes bust, files Chapter 11 bankruptcyFebruary 14, 2024 | msn.comImplant Maker Sientra Cleared to Draw Deerfield Bankruptcy LoanFebruary 13, 2024 | marketwatch.comHealth Care Limits Losses Amid Defensive Bias -- Health Care RoundupFebruary 13, 2024 | wsj.comBreast-Implant Maker Sientra Files for BankruptcyFebruary 13, 2024 | benzinga.comNasdaq Down Over 2%; Marriott Earnings Top ViewsFebruary 13, 2024 | markets.businessinsider.comSientra Files For Bankruptcy; Stock Tanks 65%February 13, 2024 | msn.comBreast-Implant Maker Sientra Files Bankruptcy After Consumer PullbackFebruary 13, 2024 | benzinga.comDow Dips Over 300 Points; US Annual Inflation Slows to 3.1% In JanuaryFebruary 13, 2024 | msn.comSientra drops on filing of voluntary Chapter 11 BankruptcyFebruary 13, 2024 | wsj.comSurgical Aesthetics Company Sientra Files for BankruptcyFebruary 13, 2024 | finance.yahoo.comSientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessFebruary 1, 2024 | benzinga.comSientra Stock (NASDAQ:SIEN) Dividends: History, Yield and DatesJanuary 30, 2024 | businesswire.comGlobal Breast Implants Market Industry Trends and Global Forecasts 2023-2035 - Distribution by Gender, End User, Distribution Channel and Key Geographical Regions ...January 30, 2024 | msn.comSientra Secures Amendment for Financial FlexibilitySee More Headlines Receive SIEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sientra and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:SIEN CUSIPN/A CIK1551693 Webwww.sientra.com Phone(805) 562-3500Fax805-562-8401Employees304Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($5.57) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,310,000.00 Net Margins-65.93% Pretax Margin-65.68% Return on EquityN/A Return on Assets-40.45% Debt Debt-to-Equity RatioN/A Current Ratio0.57 Quick Ratio0.31 Sales & Book Value Annual Sales$90.55 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / BookN/AMiscellaneous Outstanding Shares11,960,000Free Float11,775,000Market Cap$2.08 million OptionableOptionable Beta2.04 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Ronald Menezes (Age 61)President, CEO & Director Comp: $501.18kMr. Andrew C. Schmidt (Age 63)Senior VP, Treasurer & CFO Comp: $365.4kMr. Oliver Christian Bennett (Age 47)Senior VP, Chief Legal, Compliance, & Corporate Development Officer Comp: $363.37kMr. Keith J. Sullivan (Age 66)Director & Advisor to MiraDry Business Comp: $40kMs. Caroline F. Van Hove (Age 43)Executive Chair of Board of Directors Comp: $197.74kDr. Denise DajlesChief Technical OfficerMr. Mark S. Saxton (Age 59)Senior Vice President Sales Ms. Adelle WalkerSenior Vice President of Corporate Strategy & MarketingMr. Matt HostetlerChief People OfficerMore ExecutivesKey CompetitorsXylo TechnologiesNASDAQ:MDGSNanoVibronixNASDAQ:NAOVAclarionNASDAQ:ACONNuwellisNASDAQ:NUWEClearmind MedicineNASDAQ:CMNDView All CompetitorsInstitutional OwnershipRTW Investments LPSold 223,020 shares on 2/14/2024Ownership: 0.677%Evoke Wealth LLCBought 26,473 shares on 2/12/2024Ownership: 0.370%View All Institutional Transactions SIEN Stock Analysis - Frequently Asked Questions Should I buy or sell Sientra stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SIEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SIEN, but not buy additional shares or sell existing shares. View SIEN analyst ratings or view top-rated stocks. How were Sientra's earnings last quarter? Sientra, Inc. (NASDAQ:SIEN) issued its quarterly earnings results on Wednesday, November, 10th. The medical instruments supplier reported ($0.80) earnings per share for the quarter, topping the consensus estimate of ($2.60) by $1.80. The medical instruments supplier had revenue of $19.62 million for the quarter, compared to analyst estimates of $18.10 million. During the same quarter last year, the firm posted ($3.30) earnings per share. When did Sientra's stock split? Shares of Sientra reverse split on the morning of Monday, January 23rd 2023. The 1-10 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Sientra own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Rigel Pharmaceuticals (RIGL), Matinas BioPharma (MTNB), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), ADMA Biologics (ADMA), Miragen Therapeutics (MGEN), Corbus Pharmaceuticals (CRBP), Dynavax Technologies (DVAX), Micron Technology (MU) and Novavax (NVAX). This page (NASDAQ:SIEN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sientra, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
